EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 147 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,871,484 | +319.1% | 65,967 | +331.8% | 0.00% | +300.0% |
| Q4 2022 | $446,517 | -54.4% | 15,276 | -34.9% | 0.00% | -75.0% |
| Q1 2021 | $979,000 | -66.4% | 23,449 | -54.5% | 0.00% | -82.6% |
| Q3 2019 | $2,918,000 | +47.4% | 51,590 | +45.1% | 0.02% | +43.8% |
| Q2 2019 | $1,979,000 | -61.0% | 35,550 | -64.6% | 0.02% | -33.3% |
| Q1 2019 | $5,068,000 | +12.9% | 100,376 | -9.9% | 0.02% | -47.8% |
| Q4 2018 | $4,490,000 | +1878.0% | 111,464 | +2492.2% | 0.05% | +411.1% |
| Q1 2018 | $227,000 | -94.1% | 4,300 | -90.9% | 0.01% | -82.0% |
| Q2 2015 | $3,842,000 | – | 47,509 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |